Q3'23 Revenue from Continuing Business of $269.4 million, up 39% year over year Value-Based Consumers served of 355,000, an increase of 208.7% on a comparable basis from last year on strong growth in Care Delivery Q3'23 Net Loss from Continuing Business of $479.3 million, including a $401.4 million non-cash Goodwill impairment charge; Positive Adjusted EBITDA of $1.2 million in Q3'23 Maintaining expectation for 2023 consolidated Adjusted EBITDA profitability† Bright Health Group, Inc. ("Bright Health" or the "Company") (NYSE:BHG), the technology enabled, value-driven healthcare company serving aging and underserved consumers with unmet clinical needs, today reported financial r

Bright Health Group, Inc. ("Bright Health") (NYSE:BHG), the technology enabled, value-driven healthcare company, today announced it will report Third Quarter financial results before the financial markets open on Tuesday, November 7, 2023, followed by a conference call at 8:00 AM Eastern Time. To participate via telephone, please pre-register at this link. Upon registration, telephone participants will receive a confirmation email detailing how to join the conference call, including dial-in number, conference number, and personal code that can be used to access the call. A webcast of the earnings call may also be accessed via Bright Health's Investor Relations page at investors.brighthe

Q2'23 Revenue from Continuing Business of $298.0 million, up 100% year over year Value-Based Consumers served of 371,000, an increase of 214% on a comparable basis from last year on strong growth in Care Delivery Q2'23 Net Loss from Continuing Business of $31.7 million; Positive Adjusted EBITDA of $6.4 million in Q2'23, positive Operating Income in Care Delivery and Care Solutions segments Maintaining expectation for 2023 consolidated Adjusted EBITDA profitability† Bright Health Group, Inc. ("Bright Health" or the "Company") (NYSE:BHG), the technology enabled, value-driven healthcare company serving aging and underserved consumers with unmet clinical needs, today reported fi

Enters $60 million credit facility with NEA Announces entering permanent waiver of default on existing credit facility Bright Health Group, Inc. ("Bright Health" or the "Company") (NYSE:BHG), the technology enabled, value-driven healthcare company, today announced that it entered into a credit facility with an investment partnership of New Enterprise Associates ("NEA") with $60 million of credit capacity on August 4, 2023. Bright Health is also announcing that it has entered into a permanent waiver of default on its existing credit facility, which expires in February 2024. Mike Mikan, President and CEO of Bright Health, said, "We are excited to have the continued support of NEA, an

Bright Health Group, Inc. ("Bright Health") (NYSE:BHG), the technology enabled, value-driven healthcare company serving aging and underserved consumers with unmet clinical needs, today announced it will report Second Quarter financial results before the financial markets open on Wednesday, August 9, 2023, followed by a conference call at 8:00 AM Eastern Time. To participate via telephone, please pre-register at this link. Upon registration, telephone participants will receive a confirmation email detailing how to join the conference call, including dial-in number, conference number, and personal code that can be used to access the call. A webcast of the earnings call may also be accesse

Q1'23 Revenue from Continuing Business of $756.3 million, up 23% year over year on strong growth in Consumer Care external value-based consumers served Q1'23 Net Loss from Continuing Business of $94.8 million, Adjusted EBITDA Loss of $35.1 million Consumer Care segment generated positive Operating Income in Q1'23 Q1'23 California MCR was 89.0% excluding prior period Medical Costs, consistent with seasonal expectations Maintaining expectation for 2023 consolidated Adjusted EBITDA profitability† Bright Health Group, Inc. ("Bright Health" or the "Company") (NYSE:BHG), the technology enabled, value-driven healthcare company serving aging and underserved consumers with unmet clin

Bright Health Group, Inc. ("Bright Health") (NYSE:BHG), the technology enabled, value-driven healthcare company serving aging and underserved consumers with unmet clinical needs, today announced it will report First Quarter financial results before the financial markets open on Tuesday, May 9, 2023, followed by a conference call at 8:00 AM Eastern Time. To participate via telephone, please pre-register at this link. Upon registration, telephone participants will receive a confirmation email detailing how to join the conference call, including dial-in number, conference number, and personal code that can be used to access the call. A webcast of the earnings call may also be accessed via

Bright Health Group, Inc. ("Bright Health") (NYSE:BHG), the technology enabled, value-driven healthcare company serving aging and underserved consumers with unmet clinical needs, today announced it will report Fourth Quarter financial results before the financial markets open on Wednesday, March 1, 2023, followed by a conference call at 8:00 AM Eastern Time. To participate via telephone, please pre-register at this link. Upon registration, telephone participants will receive a confirmation email detailing how to join the conference call, including dial-in number, conference number, and personal code that can be used to access the call. A webcast of the earnings call may also be accessed v

Bright Health Group, Inc. ("Bright Health") (NYSE:BHG) today announced it will report Third Quarter financial results before the financial markets open on Wednesday, November 9, 2022, followed by a conference call at 8:00 AM Eastern Time. To participate via telephone, please pre-register at this link. Upon registration, telephone participants will receive a confirmation email detailing how to join the conference call, including dial-in number, conference number, and personal code that can be used to access the call. A webcast of the earnings call may also be accessed via Bright Health's Investor Relations page at investors.brighthealthgroup.com. The company suggests participants for the c

Reaffirms previous 2022 Adjusted EBITDA guidance at midpoint and accelerates Adjusted EBITDA profitability to 2023, a year earlier than previously anticipated Will no longer offer Individual and Family Plan products through Bright HealthCare in 2023, or Medicare Advantage products outside of California and Florida Raises $175 million of committed convertible preferred equity capital to fully fund business to profitability Expects to deliver a $3 billion Net Revenue balanced business in 2023 through its risk-bearing care delivery and Medicare Advantage businesses Bright Health Group, Inc. ("Bright Health") (NYSE:BHG) today announced its decision to further focus its business on its

The Company will advance its value-driven, consumer-centric care model through its owned and affiliated clinics and provider enablement services Bright Health Group, Inc. ("Bright Health" or the "Company") (NYSE:BHG) today announced that it has adopted NeueHealth as its corporate brand name. This reflects the Company's ongoing focus on its NeueHealth business, which will continue driving long-term sustainable growth of its value-driven, consumer-centric care model, thereby increasing access to high-quality healthcare for all populations across the ACA Marketplace, Medicare, and Medicaid. The Company's common stock will begin trading under the new ticker symbol "NEUE" on the New York Stock

Completes final repayment on secured credit facility eliminating the Company's secured debt Further focuses on increasing access to value-driven healthcare for all populations across the ACA Marketplace, Medicare, and Medicaid through its continuing business, NeueHealth Reaffirms expectation for Adjusted EBITDA profitability in 2024 Bright Health Group, Inc. ("Bright Health" or the "Company") (NYSE:BHG), the technology enabled, value-driven healthcare company, today announced that it has successfully completed the sale of its California Medicare Advantage business, Brand New Day and Central Health Plan, to Molina Healthcare, Inc. ("Molina"). The sale closed, effective as of Januar

Received all required regulatory approvals on the sale of the California Medicare Advantage business; the transaction is expected to close on or about January 1, 2024 Amended Company's secured credit facility to reduce the final repayment resulting in approximately $30 million in savings Meaningfully improves capital position to support continuing business, NeueHealth, a value-driven consumer care delivery and provider enablement business Bright Health Group, Inc. ("Bright Health" or the "Company") (NYSE:BHG), the technology enabled, value-driven healthcare company, today announced that it entered into an amendment to its credit facility with J.P. Morgan that will reduce the final

  The statements contained in this document are solely those of the authors and do not necessarily reflect the views or policies of CMS. The authors assume responsibility for the accuracy and completeness of the information contained in this document. Medical Home Network (MHN) provider partners participating in NeueHealth Premier ACO achieved $10.1 million in gross savings and a 100% quality score in the 2022 performance year, according to data recently released from the Centers for Medicare and Medicaid Services (CMS). These results were achieved under the Global and Professional Direct Contracting Model, now known as the ACO Realizing Equity, Access, and Community Health (REACH) Mode

Q3'23 Revenue from Continuing Business of $269.4 million, up 39% year over year Value-Based Consumers served of 355,000, an increase of 208.7% on a comparable basis from last year on strong growth in Care Delivery Q3'23 Net Loss from Continuing Business of $479.3 million, including a $401.4 million non-cash Goodwill impairment charge; Positive Adjusted EBITDA of $1.2 million in Q3'23 Maintaining expectation for 2023 consolidated Adjusted EBITDA profitability† Bright Health Group, Inc. ("Bright Health" or the "Company") (NYSE:BHG), the technology enabled, value-driven healthcare company serving aging and underserved consumers with unmet clinical needs, today reported financial r

Bright Health Group, Inc. ("Bright Health") (NYSE:BHG), the technology enabled, value-driven healthcare company, today announced it will report Third Quarter financial results before the financial markets open on Tuesday, November 7, 2023, followed by a conference call at 8:00 AM Eastern Time. To participate via telephone, please pre-register at this link. Upon registration, telephone participants will receive a confirmation email detailing how to join the conference call, including dial-in number, conference number, and personal code that can be used to access the call. A webcast of the earnings call may also be accessed via Bright Health's Investor Relations page at investors.brighthe

Medical claims runout is estimated to be over 98% complete and continues to track with prior forecasts Completed payments to fully satisfy risk adjustment obligations in seven states Enters into repayment agreements with CMS and four states to fully satisfy all remaining risk adjustment obligations over the next 18 months Bright Health Group, Inc. ("Bright Health" or the "Company") (NYSE:BHG), the technology enabled, value-driven healthcare company, today announced it continues to make progress on the wind-down of its ACA insurance business. The Company has made significant progress paying down its medical claims obligations and is on track with prior forecasts. As of the end of

Q2'23 Revenue from Continuing Business of $298.0 million, up 100% year over year Value-Based Consumers served of 371,000, an increase of 214% on a comparable basis from last year on strong growth in Care Delivery Q2'23 Net Loss from Continuing Business of $31.7 million; Positive Adjusted EBITDA of $6.4 million in Q2'23, positive Operating Income in Care Delivery and Care Solutions segments Maintaining expectation for 2023 consolidated Adjusted EBITDA profitability† Bright Health Group, Inc. ("Bright Health" or the "Company") (NYSE:BHG), the technology enabled, value-driven healthcare company serving aging and underserved consumers with unmet clinical needs, today reported fi

Enters $60 million credit facility with NEA Announces entering permanent waiver of default on existing credit facility Bright Health Group, Inc. ("Bright Health" or the "Company") (NYSE:BHG), the technology enabled, value-driven healthcare company, today announced that it entered into a credit facility with an investment partnership of New Enterprise Associates ("NEA") with $60 million of credit capacity on August 4, 2023. Bright Health is also announcing that it has entered into a permanent waiver of default on its existing credit facility, which expires in February 2024. Mike Mikan, President and CEO of Bright Health, said, "We are excited to have the continued support of NEA, an

Bright Health Group, Inc. ("Bright Health") (NYSE:BHG), the technology enabled, value-driven healthcare company serving aging and underserved consumers with unmet clinical needs, today announced it will report Second Quarter financial results before the financial markets open on Wednesday, August 9, 2023, followed by a conference call at 8:00 AM Eastern Time. To participate via telephone, please pre-register at this link. Upon registration, telephone participants will receive a confirmation email detailing how to join the conference call, including dial-in number, conference number, and personal code that can be used to access the call. A webcast of the earnings call may also be accesse

4 - Bright Health Group Inc. (0001671284) (Issuer)

4 - Bright Health Group Inc. (0001671284) (Issuer)

4 - Bright Health Group Inc. (0001671284) (Issuer)

4 - Bright Health Group Inc. (0001671284) (Issuer)

4 - Bright Health Group Inc. (0001671284) (Issuer)

4 - Bright Health Group Inc. (0001671284) (Issuer)

4 - Bright Health Group Inc. (0001671284) (Issuer)

4 - Bright Health Group Inc. (0001671284) (Issuer)

4 - Bright Health Group Inc. (0001671284) (Issuer)

4 - Bright Health Group Inc. (0001671284) (Issuer)

8-K - Bright Health Group Inc. (0001671284) (Filer)

8-K - Bright Health Group Inc. (0001671284) (Filer)

8-K - Bright Health Group Inc. (0001671284) (Filer)

8-K - Bright Health Group Inc. (0001671284) (Filer)

8-K - Bright Health Group Inc. (0001671284) (Filer)

10-Q - Bright Health Group Inc. (0001671284) (Filer)

8-K - Bright Health Group Inc. (0001671284) (Filer)

8-K - Bright Health Group Inc. (0001671284) (Filer)

8-K - Bright Health Group Inc. (0001671284) (Filer)

8-K/A - Bright Health Group Inc. (0001671284) (Filer)

Cathy Smith to Step Down to Pursue New Opportunity, Effective May 12, 2023 Bright Health Group, Inc. ("Bright Health" or the "Company") (NYSE:BHG), the technology enabled, value-driven healthcare company serving aging and underserved consumers with unmet clinical needs, today announced that it has appointed Jay Matushak as the Company's next Chief Financial Officer, effective May 12, 2023. Mr. Matushak will succeed Cathy Smith, who is stepping down to pursue another opportunity. Mr. Matushak, a seasoned finance and operational executive with deep expertise in the healthcare business, joined Bright Health in 2021. He currently serves as Senior Vice President of Finance and is responsible

Jeff Craig, lead counsel for the Company's NeueHealth business, named General Counsel and Corporate Secretary Bright Health Group, Inc. ("Bright Health" or "The Company") (NYSE:BHG), the first technology-enabled, Fully Aligned system of care built for healthcare's consumer retail market, today announced that Keith Nelsen will retire as General Counsel and Corporate Secretary. Jeff Craig, lead counsel for the Company's NeueHealth business, will be promoted to the role of General Counsel and Corporate Secretary effective March 18, 2022. Nelsen will stay on as a senior advisor with the Company until June 30, 2022, to ensure a smooth transition. "Keith has been a key leader for many of our mi

Matthew Manders to Join as Independent Director Bright Health Group, Inc. ("Bright Health") (NYSE:BHG), the first technology-enabled, Fully Aligned system of care built for healthcare's consumer retail market, today announced that leading healthcare expert Matt Manders will join the company's Board as an independent director, effective March 1. Manders brings a wealth of diverse healthcare experience, focus on operational excellence, and expertise in consumer-driven healthcare. Most recently, he served as president of Cigna Corporation's Government and Solutions organization, part of a 30-plus-year career with the company. In this role, Manders led and managed Cigna's U.S. Government busi

Company seeks to unlock the power of nature's sweet plant proteins; Wing brings broad expertise across consumer-focused industries as a founder and growth leader focused on healthy living Joywell Foods, a food technology and consumer goods company specializing in sweet plant proteins, announces the appointment of Ali Wing as Chief Executive Officer who joined earlier this year. Wing comes to Joywell as an experienced growth leader. Most recently, Wing served as the chief consumer officer of a healthcare technology company, Bright Health (NYSE:BHG). Prior to Bright Health, Ali's career has spanned consumer goods, retail and technology as a brand leader at companies including giggle and NIK

SC 13G/A - NeueHealth, Inc. (0001671284) (Subject)

SC 13D/A - NeueHealth, Inc. (0001671284) (Subject)

SC 13D/A - Bright Health Group Inc. (0001671284) (Subject)

SC 13D/A - Bright Health Group Inc. (0001671284) (Subject)

SC 13D/A - Bright Health Group Inc. (0001671284) (Subject)

SC 13D/A - Bright Health Group Inc. (0001671284) (Subject)

SC 13D/A - Bright Health Group Inc. (0001671284) (Subject)

SC 13D/A - Bright Health Group Inc. (0001671284) (Subject)

SC 13D/A - Bright Health Group Inc. (0001671284) (Subject)

SC 13D - Bright Health Group Inc. (0001671284) (Subject)

JP Morgan downgraded Bright Health Group from Neutral to Underweight

JP Morgan downgraded Bright Health Group from Overweight to Neutral

RBC Capital downgraded Bright Health Gr from Outperform to Sector Perform and set a new price target of $3.00 from $9.00 previously

Morgan Stanley reiterated coverage of Bright Health Gr with a rating of Underweight and set a new price target of $2.00 from $4.00 previously

Goldman Sachs reiterated coverage of Bright Health Gr with a rating of Neutral and set a new price target of $3.50 from $5.00 previously

Barclays reiterated coverage of Bright Health Gr with a rating of Overweight and set a new price target of $4.00 from $5.50 previously

Piper Sandler reiterated coverage of Bright Health Gr with a rating of Overweight and set a new price target of $5.00 from $10.00 previously

BofA Securities downgraded Bright Health Group from Buy to Underperform

Citigroup resumed coverage of Bright Health Group with a rating of Neutral and set a new price target of $3.50 from $5.00 previously

Barclays reiterated coverage of Bright Health Gr with a rating of Overweight and set a new price target of $5.50 from $9.00 previously

The Company will advance its value-driven, consumer-centric care model through its owned and affiliated clinics and provider enablement servicesBright Health Group, Inc. ("Bright Health" or the "Company") (NYSE:BHG) today announced that it has adopted NeueHealth as its corporate brand name. This reflects the Company's ongoing focus on its NeueHealth business, which will continue driving long-term sustainable growth of its value-driven, consumer-centric care model, thereby increasing access to high-quality healthcare for all populations across the ACA Marketplace, Medicare, and Medicaid. The Company's common stock will begin trading under the new ticker symbol "NEUE" on the New York Stock Exc

Shares of RxSight, Inc. (NASDAQ:RXST) rose sharply during Monday’s session after the company issued preliminary FY23 and FY24 revenue guidance above estimates. Also, Needham maintained a Buy rating on the stock and raised its price target from $35 to $41. RxSight shares jumped 20% to $44.31 on Monday. Here are some other stocks moving in today's mid-day session. Gainers Harpoon Therapeutics, Inc. (NASDAQ:HARP) shares jumped 111.2% to $22.28 after Merck announced it will acquire the company for $23 per share in cash. Ambrx Biopharma Inc. (NASDAQ:AMAM) jumped 98.1% to $27.00 after Johnson & Johnson announced it will acquire the company in an all-cash merger for a total equity value

Gainers Omega Therapeutics (NASDAQ:OMGA) shares increased by 99.6% to $5.45 during Thursday's regular session. The market value of their outstanding shares is at $300.5 million. Avenue Therapeutics (NASDAQ:ATXI) shares increased by 56.08% to $0.27. The company's market cap stands at $3.6 million. Dyne Therapeutics (NASDAQ:DYN) stock rose 30.28% to $19.24. The market value of their outstanding shares is at $1.1 billion. Adicet Bio (NASDAQ:ACET) shares moved upwards by 25.0% to $2.2. The company's market cap stands at $94.9 million. Bright Health Gr (NYSE:BHG) stock increased by 24.15% to $11.36. The company's market cap stands at $90.6 million. Werewolf Therapeutics (NASDAQ:HOWL) shares

According to Benzinga Pro following are the gainers and losers in Insurance industry for today's Intraday session. Gainers SelectQuote (NYSE:SLQT) shares rose 6.75% to $1.58 during Wednesday's regular session. Trading volume for SelectQuote's stock is 397.8K as of 12:40 EST. This is 0% of its average full-day volume over the last 100 days. The company's market cap stands at $249.9 million. Hippo Holdings (NYSE:HIPO) shares increased by 4.74% to $9.27. As of 12:40 EST, Hippo Holdings's stock is trading at a volume of 57.1K, which is 0% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $211.4 million. GoHealth (NASDAQ:GOCO) stock move

According to Benzinga Pro following are the gainers and losers in Insurance industry for today's Intraday session. Gainers Oxbridge Re Holdings (NASDAQ:OXBR) stock moved upwards by 5.65% to $1.09 during Wednesday's regular session. Trading volume for this security as of 12:40 EST is 1.1K, which is 0% of its average full-day volume over the last 100 days. The company's market cap stands at $6.4 million. Trupanion (NASDAQ:TRUP) shares rose 2.55% to $30.1. Trading volume for this security as of 12:40 EST is 153.1K, which is 0% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $1.2 billion. Brighthouse Finl (NASDAQ:BHFAN) stock moved up